Detalles de la búsqueda
1.
Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.
Oncologist
; 25(4): 306-e618, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32297438
2.
Chemotherapy should be performed in epidermal growth factor receptor mutation-positive lung adenocarcinoma patients who had progressive disease to the first epidermal growth factor receptor-tyrosine kinase inhibitor.
Anticancer Drugs
; 31(9): 959-965, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32889898
3.
Timing of resumption of immune checkpoint inhibitor therapy after successful control of immune-related adverse events in seven advanced non-small cell lung cancer patients.
Anticancer Drugs
; 31(8): 872-875, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32796406
4.
Toxicity and Efficacy of Sequential Chemotherapy in Patients with p-stage I Non-small Cell Lung Cancer that Recurring during Postoperative Tegafur-Uracil Adjuvant Chemotherapy.
Cancer Invest
; 36(8): 424-430, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30234395
5.
Preoperative Percutaneous Transthoracic Needle Biopsy Increased the Risk of Pleural Recurrence in Pathological Stage I Lung Cancer Patients With Sub-pleural Pure Solid Nodules.
Cancer Invest
; 34(8): 373-7, 2016 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27532604
6.
The Ratio KL-6 to SLX in Serum for Prediction of the Occurrence of Drug-Induced Interstitial Lung Disease in Lung Cancer Patients with Idiopathic Interstitial Pneumonias Receiving Chemotherapy.
Cancer Invest
; 33(10): 516-21, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26305851
7.
Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases.
Mod Rheumatol
; 24(2): 361-5, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24593215
8.
Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in Elderly Patients With Malignant Central Airway Obstruction: A Retrospective Single-institution Study.
Am J Clin Oncol
; 47(5): 223-227, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38251717
9.
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study.
Eur J Cancer
; 179: 15-24, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36470023
10.
Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP).
Lung Cancer
; 186: 107426, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37992594
11.
Galectin-9 attenuates acute lung injury by expanding CD14- plasmacytoid dendritic cell-like macrophages.
Am J Respir Crit Care Med
; 184(3): 328-39, 2011 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21562126
12.
Difference in the Overall Survival Between Malignant Central Airway Obstruction Patients Treated by Transbronchial Microwave Ablation and Stent Placement: A Single-institution Retrospective Study.
Anticancer Res
; 42(6): 3125-3131, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641276
13.
Prognosis of stage I non-small cell lung cancer patients aged ≥ 80 years who were considered medically operable but received best supportive care alone.
Cancer Treat Res Commun
; 33: 100642, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36174378
14.
Overall Survival of Small-cell Lung Cancer Patients With Malignant Central Airway Obstruction Who Received Chemotherapy Without Undergoing Transbronchial Interventions: A Single-institution Retrospective Study.
Anticancer Res
; 42(12): 6113-6119, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36456147
15.
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World Setting.
Chest
; 162(5): 1188-1198, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35661746
16.
Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study.
J Cancer Res Clin Oncol
; 147(1): 287-293, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32761377
17.
Efficacy and safety of transbronchial microwave ablation therapy under moderate sedation in malignant central airway obstruction patients with respiratory failure: a single-institution retrospective study.
J Cancer Res Clin Oncol
; 147(9): 2751-2757, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33629194
18.
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).
Eur J Cancer
; 159: 144-153, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34749119
19.
Prognosis of EGFR-mutant Lung Adenocarcinoma Patients With Malignant Pleural Effusion Receiving First-line EGFR-TKI Therapy Without Pleurodesis: A Single-institute Retrospective Study.
Anticancer Res
; 40(2): 1117-1121, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32014962
20.
Additional bevacizumab in EGFR-mutant lung adenocarcinoma patients who had oligo-progression after the failure of EGFR-TKI: A single-institute retrospective study.
Cancer Treat Res Commun
; 22: 100163, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31675534